• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在墨西哥开发一个基因组医学平台。

Developing a platform for genomic medicine in Mexico.

作者信息

Jimenez-Sanchez Gerardo

机构信息

Consortium for the Institute of Genomic Medicine of Mexico, Camino al Ajusco 130-101, Col. Jardines en la Montaña, Mexico DF 14210, Mexico.

出版信息

Science. 2003 Apr 11;300(5617):295-6. doi: 10.1126/science.1084059.

DOI:10.1126/science.1084059
PMID:12690190
Abstract

Mexico is preparing to develop a genomic medicine program focused on national health problems. Modern Mexicans result from an admixture of more than 65 native Indian groups with Spaniards, leading to a unique genetic makeup and a characteristic set of disease susceptibilities. Since 1999, more than 100 experts from different fields have joined efforts with government, academia, and industry to identify priorities and goals for genomic medicine in Mexico. The plan includes establishment of an Institute of Genomic Medicine with strong intramural and extramural programs. This project is expected to ease the social and financial burden of health problems in Mexico.

摘要

墨西哥正准备开展一项针对本国健康问题的基因组医学项目。现代墨西哥人是65多个本土印第安群体与西班牙人混合的后裔,这导致了独特的基因构成和一系列特有的疾病易感性。自1999年以来,来自不同领域的100多名专家与政府、学术界和产业界共同努力,确定墨西哥基因组医学的优先事项和目标。该计划包括建立一个拥有强大内部和外部项目的基因组医学研究所。预计该项目将减轻墨西哥健康问题带来的社会和经济负担。

相似文献

1
Developing a platform for genomic medicine in Mexico.在墨西哥开发一个基因组医学平台。
Science. 2003 Apr 11;300(5617):295-6. doi: 10.1126/science.1084059.
2
Genomic medicine in Mexico: initial steps and the road ahead.墨西哥的基因组医学:初步进展与未来之路。
Genome Res. 2008 Aug;18(8):1191-8. doi: 10.1101/gr.065359.107.
3
[Opportunities for the pharmaceutical industry at the Mexican Genomic Medicine Institute].[墨西哥基因组医学研究所给制药行业带来的机遇]
Gac Med Mex. 2002 May-Jun;138(3):291-4.
4
[Education needs for the development of binational programs of health care].
Salud Publica Mex. 1992 Sep-Oct;34(5):562-8.
5
Calling for international collaborative research in nursing, genetics and genomics: a discussion paper.呼吁开展护理、遗传学和基因组学领域的国际合作研究:一篇讨论文件。
Int J Nurs Stud. 2008 Feb;45(2):323-8. doi: 10.1016/j.ijnurstu.2006.08.013. Epub 2006 Oct 9.
6
[The Institute of Social Security and Social Service for Government Workers. Its participation in the National Health Plan].[政府工作人员社会保障与社会服务研究所。其参与国家卫生计划的情况]
Salud Publica Mex. 1974 Nov-Dec;16(6):881-4.
7
A commentary on domestic animals as dual-purpose models that benefit agricultural and biomedical research.关于家畜作为有益于农业和生物医学研究的两用模型的评论。
J Anim Sci. 2008 Oct;86(10):2797-805. doi: 10.2527/jas.2008-1088. Epub 2008 Jun 20.
8
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
9
Will genomics widen or help heal the schism between medicine and public health?基因组学会扩大还是有助于弥合医学与公共卫生之间的分歧?
Am J Prev Med. 2007 Oct;33(4):310-7. doi: 10.1016/j.amepre.2007.05.010.
10
Genetics and genomic medicine.遗传学与基因组医学。
Radiol Technol. 2009 Mar-Apr;80(4):318-35; quiz 336-9.

引用本文的文献

1
Longitudinal assessment of SNPs rs72552763 and rs622342 in over HbA1c control among Mexican-Mestizo diabetic type 2 patients.对墨西哥梅斯蒂索2型糖尿病患者中SNP rs72552763和rs622342在糖化血红蛋白(HbA1c)控制情况方面的纵向评估。
Front Pharmacol. 2024 Sep 30;15:1433519. doi: 10.3389/fphar.2024.1433519. eCollection 2024.
2
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients.二甲双胍转运体的药物遗传学表明与2型糖尿病墨西哥患者的治疗无效无关。
Pharmaceuticals (Basel). 2022 Jun 22;15(7):774. doi: 10.3390/ph15070774.
3
A Bibliometric Analysis of Mexican Bioinformatics: A Portrait of Actors, Structure, and Dynamics.
墨西哥生物信息学的文献计量分析:参与者、结构与动态概述
Biology (Basel). 2022 Jan 13;11(1):131. doi: 10.3390/biology11010131.
4
External validation of the relative fat mass (RFM) index in adults from north-west Mexico using different reference methods.采用不同参考方法对来自墨西哥西北部的成年人进行相对脂肪质量(RFM)指数的外部验证。
PLoS One. 2019 Dec 31;14(12):e0226767. doi: 10.1371/journal.pone.0226767. eCollection 2019.
5
Frequency of (, and ) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin.接受格列本脲和二甲双胍治疗的墨西哥2型糖尿病患者中(、和)等位基因变体的频率及其临床意义。
Biomed Rep. 2019 May;10(5):283-295. doi: 10.3892/br.2019.1204. Epub 2019 Apr 4.
6
Genomics for All: International Open Science Genomics Projects and Capacity Building in the Developing World.全民基因组学:国际开放科学基因组学项目与发展中世界的能力建设
Front Genet. 2019 Feb 15;10:95. doi: 10.3389/fgene.2019.00095. eCollection 2019.
7
Confidentiality and data sharing: vulnerabilities of the Mexican Genomics Sovereignty Act.保密性与数据共享:墨西哥《基因组主权法案》的漏洞
J Community Genet. 2015 Jul;6(3):313-9. doi: 10.1007/s12687-015-0233-5. Epub 2015 May 20.
8
Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.印度北部人群中药物代谢、药物转运体及药物靶基因多态性在耐药性癫痫中作用的药物基因组关联研究
Indian J Hum Genet. 2011 May;17 Suppl 1(Suppl 1):S32-40. doi: 10.4103/0971-6866.80357.
9
Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico.分析墨西哥梅斯蒂索人群的基因组多样性以发展墨西哥的基因组医学。
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8611-6. doi: 10.1073/pnas.0903045106. Epub 2009 May 11.
10
Development of genomic sciences in Mexico: a good start and a long way to go.墨西哥基因组科学的发展:良好开端,任重道远。
PLoS Comput Biol. 2007 Sep;3(9):1670-3. doi: 10.1371/journal.pcbi.0030143.